INTRODUCTIONCANADIAN CANNABIS STOCK MARKET

 cannabis 1Investment Overview:

It is an exciting time to be in the cannabis business. What’s going on in Canada is as exciting as what is happening the United States. In fact, most of the volume and money is flowing into the Canadian Green Rush. We welcome you to cannabisstockpicks where we focus on US and Canadian Cannabis Stocks. We welcome you to join us in exploring the most exciting opportunity since prohibition!

We stress that, at this time, our company reviews are informational and not recommendations to purchase shares. When the fundamentals, technicals, news flow, and overall market give us a "buy signal”, we will provide specific buy recmmendations then.

Market Dynamics:

Recreational Use. Canada’s government said on 12/13 it would study a federal task force’s recommendation that Canadians over 18 years old be allowed to buy marijuana for recreational purposes and would announce new laws in the Spring for legalizing pot. Prime Minister Trudeau has long promised to legalize recreational pot use and sales.

Limited Licenses. Canada's stance to limit the number of licenses for growers, distributors, etc., is of special interest to investors. That practice by the state opens up the possibility to create large, robust companies. And venture firms are happy to back those. The three leading Canadian cannabis companies — Aurora Cannabis, Aphria and Canopy Growth — have each raised nearly $30 million from investors. Investors could win big by picking the winning company that is protected from future competition through a license. 

International Opportunities. Globally, $150 billion was spent last year on marijuana in 2015, according to studies. Investors myopically focused on the just the United States while miss so much of the opportunity. The Great White North (aka Canada) was the first country to legalize medical marijuana on a federal level in 2001. Others around the world are looking to Canada and likely to follow its lead. Getting to know the Canada Cannabis market is a smart bet for investors.

Canopy Growth Corp

CR 1

 

Canopy Growth Corp is based in Ontario. Canopy, formerly Tweed Marijuana Inc, is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan.

Aurora Cannabis (CVE:ACB)

CR2

Aurora Cannabis is based in Vancouver. The company is engaged in the production and sale of medical cannabis. The Company is engaged in the business of producing and distributing medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company's product types include Tetrahydrocannabinol (THC), Cannabidiole (CBD), indica, sativa and hybrid. Its product range includes BLACK TUSK 2, CHESTER, KAINE and TOWER. The Company is also focusing on other products, which will be available for sale either as pre-milled buds (Borealis Blends) or as whole buds.

Emblem Corp

CR3

Emblem Corp is based in Vancouver. Emblem operates three distinct divisions which can create value for each other: Emblem Cannabis (the production division), Emblem Pharmaceutical, and GrowWise Health (marijuana education for patients and physicians). The Emblem Pharmaceutical division is led by John H. Stewart, who launched 11 new products, including OxyContin while he was President and CEO of Purdue Pharma, one of the largest privately held pharmaceutical companies in the world.

Aphria

aphria 1---

When Health Canada, Canada’s federal health authority that governs cannabis regulation, first licensed Aphria Inc. to produce medical marijuana in November, 2014, it appeared that the company might be late to the dance. By that time 13 other companies had been issued grow licenses, so the field was already quite crowded. Over the past two years, however, Aphria has quickly emerged as one of the heaviest hitters in Canada’s rapidly growing cannabis industry.

One month after receiving its license, in December, 2014, 52 million Aphria shares began trading on Toronto’s TSX venture exchange under the symbol APH. At the time, the company immediately caught investors’ attention, in part due to the impressive pedigree of its management team, headed by Vic Neufeld, who previously served as CEO of Jamieson Laboratories, a major vitamin manufacturer.

READ MORE.

PharmaCan Capital

CR5

PharmaCan Capital is based in Toronto. PharmaCan is a merchant bank, which is focused on investing in Canada's medical marijuana industry. The Company is engaged in the business of investing in companies either licensed or seeking a license to produce medical marijuana. The company operates through two segments: Investing Segment and Operating Segment. The Investing Segment relates to pursuing equity investments into licensed medical marijuana producers in Canada. The Operating Segment relates to production and sale of medical cannabis through its subsidiary, In the Zone Produce Ltd. The Company has invested in and made loans to companies, including The Peace Naturals Project Inc, Whistler Medical Marijuana Corporation, Vert/Green Medical Inc., Evergreen Medicinal Supply Inc., AbCann Medicinals Inc., CannMart Inc. and The Hydropothecary Corporation.

THC Biomed

cr6

THC BioMed is an organization strategically located in Kelowna, BC that is devoted to research & development, plant innovation, and life sciences, with the emphasis on Medical Cannabis. Transparency, integrity, and regulatory compliance remain the company’s focus. With Medical Cannabis being a burgeoning industry, it is imperative that substantiated scientific data and evidence is brought to the forefront by company’s like THC Biomed, delivering educational knowledge to break down the barriers, where only anecdotal information survived before.

Emerald Health Therapeutics

cr 7

Emerald Health Therapeutics is based in Victoria. The expert team has over 60 years of cannabis growing knowledge with cutting edge science to product genetically superior, high-quality medical cannabis products. Emerald is bridging the gap between cannabinoids and medicine.

Maple Leaf Green World

CR8

Maple Leaf Green World is based in Calgary. The company’s business strategies span several areas. To acquire requisite licenses and well equipped facilities in both Canada and U.S.A. with capacity to produce 20,000 KG MJ a year. To grow pesticide-free, top-grade marijuana from contamination-free soil through strong quality assurance program. To develop new cultivation methods in order to reduce cost and increase production. To develop new strains that have higher cannabidiol (CBD) than THC. To become a commercial supplier of propagules (seeds and cuttings) with high CBD to other growers, thus provide a second source of revenue for the company. To emphasize quality and non-contaminated MJ for Cannabis Oil production which can be used for medical purposes.

Cannabix Technologies

CR 9



Cannabix Technologies is based in Burnaby. Cannabix Technologies is a technology development company. The company is engaged in marijuana breathalyzer development for law enforcement and the workplace. The company is engaged in developing drug-testing devices that will detect Tetrahydrocannabinol (THC) using breath samples. The company intends to use its technology to provide detection of use of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. The company is focused on technology development and intends to carry out prototype development of the Cannabix marijuana Breathalyzer.